. (TRGT)

- - (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

(TRGT)

. (TRGT)

-
- (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
USMAN NASSIMDirectorApr 01, 2024 Option Exercise$6.9320,000138,60021,636Apr 03, 2024, 04:01 PM
USMAN NASSIMDirectorApr 01, 2024 Sale$16.1520,000323,0001,636Apr 03, 2024, 04:01 PM
USMAN NASSIMDirectorMar 15, 2024 Option Exercise$6.9320,000138,60021,636Mar 19, 2024, 04:47 PM
USMAN NASSIMDirectorMar 15, 2024 Sale$17.2620,000345,2001,636Mar 19, 2024, 04:47 PM
USMAN NASSIMPresident & CEOAug 09, 2022 Buy$0.473,2501,52724,541Aug 10, 2022, 05:19 PM
Miller Seline E.SVP Finance; Interim CFO & PAOAug 09, 2022 Buy$0.473,2501,5276,500Aug 10, 2022, 05:19 PM
Blouse Grant E.Chief Scientific OfficerAug 09, 2022 Buy$0.473,2501,5279,417Aug 10, 2022, 05:17 PM
USMAN NASSIMPresident & CEOFeb 09, 2022 Buy$0.463,2501,49521,291Feb 16, 2022, 08:13 PM
Miller Seline E.SVP Finance; Interim CFO & PAOFeb 09, 2022 Buy$0.463,2501,4953,250Feb 16, 2022, 08:10 PM
Blouse Grant E.Chief Scientific OfficerFeb 09, 2022 Buy$0.463,2501,4956,167Feb 16, 2022, 08:07 PM
USMAN NASSIMPresident & CEOAug 09, 2021 Buy$3.628673,13918,041Aug 11, 2021, 09:15 AM
Levy HowardChief Medical OfficerAug 09, 2021 Buy$3.626392,313639Aug 11, 2021, 09:14 AM
Blouse Grant E.Chief Scientific OfficerAug 09, 2021 Buy$3.621,1634,2102,917Aug 11, 2021, 09:13 AM
USMAN NASSIMPresident & CEOApr 05, 2021 Option Exercise$4.635,00023,15017,174Apr 07, 2021, 10:55 AM
USMAN NASSIMPresident & CEOFeb 09, 2021 Buy$4.815822,79912,174Feb 22, 2021, 09:33 PM
Levy HowardChief Medical OfficerFeb 09, 2021 Buy$4.811,6708,03323,390Feb 22, 2021, 09:33 PM
USMAN NASSIMPresident & CEOAug 10, 2020 Buy$4.815822,79911,592Aug 12, 2020, 04:12 PM
Levy HowardChief Medical OfficerAug 10, 2020 Buy$4.811,7688,5044,268Aug 12, 2020, 04:11 PM
Levy HowardChief Medical OfficerMar 16, 2020 Buy$4.052,50010,1312,500Mar 17, 2020, 04:23 PM
USMAN NASSIMPresident & CEOMar 13, 2020 Buy$3.914,00015,64711,010Mar 13, 2020, 06:56 PM
Richard John PDirectorMar 13, 2020 Buy$3.982,5009,9503,716Mar 13, 2020, 06:56 PM
Cai VeronicaControllerMar 13, 2020 Buy$4.112,0008,2207,353Mar 13, 2020, 06:55 PM
Williams EddieDirectorMar 04, 2020 Buy$5.782,00011,56010,839Mar 04, 2020, 12:00 AM
Ling Geoffrey M.D.DirectorFeb 25, 2020 Buy$6.233,00018,6923,000Feb 27, 2020, 04:06 PM
LAWLOR AUGUSTINEDirectorFeb 25, 2020 Sale$6.1069,401423,5060Feb 25, 2020, 04:21 PM
USMAN NASSIMPresident & CEOFeb 10, 2020 Option Exercise$6.234302,6797,010Feb 12, 2020, 08:28 PM
Levy HowardChief Medical OfficerFeb 10, 2020 Option Exercise$6.231,3588,4601,358Feb 12, 2020, 08:28 PM
Cai VeronicaControllerFeb 10, 2020 Option Exercise$6.231,67810,4545,353Feb 12, 2020, 08:27 PM
Payne FletcherChief Financial OfficerAug 12, 2019 Option Exercise$6.511,1807,6823,744Aug 12, 2019, 04:22 PM
USMAN NASSIMPresident & CEOAug 12, 2019 Option Exercise$6.514132,6896,580Aug 12, 2019, 04:21 PM
Richard John PDirectorMay 24, 2019 Buy$8.031,0008,0301,216May 28, 2019, 09:45 AM
USMAN NASSIMPresident & CEOMay 21, 2019 Option Exercise$4.634,40020,37210,567May 22, 2019, 02:17 PM
Levy HowardChief Medical OfficerMay 21, 2019 Option Exercise$4.634,40020,37216,094May 22, 2019, 12:23 PM
Payne FletcherChief Financial OfficerFeb 11, 2019 Option Exercise$7.041,0027,0543,731Feb 13, 2019, 07:19 PM
USMAN NASSIMPresident & CEOFeb 11, 2019 Option Exercise$7.043502,4646,167Feb 13, 2019, 05:01 PM
Levy HowardChief Medical OfficerFeb 11, 2019 Option Exercise$7.042,48517,49411,867Feb 13, 2019, 05:00 PM
Levy HowardChief Medical OfficerJan 31, 2019 Option Exercise$4.631,5006,9459,382Feb 04, 2019, 04:53 PM
Payne FletcherChief Financial OfficerFeb 04, 2019 Option Exercise$4.631,5036,9593,230Feb 04, 2019, 04:52 PM
USMAN NASSIMPresident & CEOJan 31, 2019 Option Exercise$4.635,72926,52511,041Feb 04, 2019, 04:51 PM
Levy HowardChief Medical OfficerNov 26, 2018 Option Exercise$4.631496907,709Nov 27, 2018, 05:01 PM
Levy HowardChief Medical OfficerNov 16, 2018 Option Exercise$4.631738017,733Nov 16, 2018, 05:56 PM
Levy HowardChief Medical OfficerNov 16, 2018 Sale$11.001731,9037,560Nov 16, 2018, 05:56 PM
HILL STEPHEN ADirectorSep 06, 2018 Option Exercise$10.071901,9131,190Sep 06, 2018, 09:41 PM
Levy HowardChief Medical OfficerMay 03, 2018 Option Exercise$4.637,56035,0037,560May 04, 2018, 04:58 PM
USMAN NASSIMPresident & CEOApr 04, 2018 Option Exercise$4.638840788Apr 06, 2018, 05:03 PM
Payne FletcherChief Financial OfficerMar 26, 2018 Option Exercise$4.635927359Mar 28, 2018, 04:11 PM
Flynn James E10% OwnerMar 08, 2018 Sale$29.152,56174,664308,198Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 08, 2018 Sale$29.156,756196,967813,147Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 07, 2018 Sale$30.002,74882,440308,526Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 07, 2018 Sale$30.007,252217,560814,013Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 06, 2018 Sale$30.8714,419445,099322,076Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 06, 2018 Sale$30.8738,0421,174,315849,763Mar 21, 2018, 04:12 PM
Flynn James E10% OwnerMar 08, 2018 Sale$29.159,317271,6311,121,345Mar 08, 2018, 05:18 PM
Flynn James E10% OwnerMar 07, 2018 Sale$30.0010,000300,0001,122,539Mar 08, 2018, 05:18 PM
Flynn James E10% OwnerMar 06, 2018 Sale$30.8752,4611,619,4141,171,839Mar 08, 2018, 05:18 PM
USMAN NASSIMPresident & CEODec 17, 2015 Buy$2.004,0008,00078,375Dec 18, 2015, 05:43 PM
Payne FletcherChief Financial OfficerDec 17, 2015 Buy$2.0010,00020,00025,032Dec 18, 2015, 05:42 PM
HILL STEPHEN ADirectorDec 17, 2015 Buy$2.035,00010,15020,711Dec 18, 2015, 05:42 PM
HILL STEPHEN ADirectorAug 28, 2015 Option Exercise$6.7212,14681,62115,711Aug 31, 2015, 03:55 PM
BARRIS PETER J10% OwnerDec 05, 2013 Sale$5.131,0005,1310Dec 05, 2013, 03:15 PM
SANDELL SCOTT D10% OwnerDec 05, 2013 Sale$5.131,0005,1310Dec 05, 2013, 03:15 PM
BARRETT M JAMES10% OwnerDec 03, 2013 Option Exercise$3.4315,00051,52515,000Dec 05, 2013, 03:07 PM
BARRETT M JAMES10% OwnerDec 05, 2013 Sale$5.131,0005,1310Dec 05, 2013, 03:07 PM
BARRETT M JAMES10% OwnerDec 03, 2013 Sale$5.3815,00080,7540Dec 05, 2013, 03:07 PM
BARRIS PETER J10% OwnerNov 21, 2013 Sale$5.165,33327,5331,000Nov 22, 2013, 05:10 PM
BARRETT M JAMES10% OwnerNov 21, 2013 Sale$5.165,33327,5331,000Nov 22, 2013, 05:09 PM
SANDELL SCOTT D10% OwnerNov 21, 2013 Sale$5.165,33327,5331,000Nov 22, 2013, 05:08 PM
BARRIS PETER J10% OwnerJun 03, 2013 Option Exercise$0.081,000756,333Jun 04, 2013, 05:47 PM
SANDELL SCOTT D10% OwnerJun 03, 2013 Option Exercise$0.081,000756,333Jun 04, 2013, 05:47 PM
BARRETT M JAMES10% OwnerJun 03, 2013 Option Exercise$0.081,000756,333Jun 04, 2013, 05:46 PM
BROWN JULIA RDirectorMay 10, 2013 Buy$5.096,00030,5346,000May 13, 2013, 04:26 PM
HILL STEPHEN APresident and CEOMar 11, 2013 Buy$4.3810,00043,78120,000Mar 11, 2013, 04:43 PM
HILL STEPHEN APresident and CEOMar 08, 2013 Buy$4.4810,00044,79610,000Mar 11, 2013, 04:43 PM
HILL STEPHEN APresident and CEOMar 11, 2013 Buy$4.3810,00043,78120,000Mar 11, 2013, 04:33 PM
HILL STEPHEN APresident and CEOMar 08, 2013 Buy$4.4810,00044,79610,000Mar 11, 2013, 04:33 PM
BVF PARTNERS L P/IL10% OwnerNov 16, 2012 Buy$4.00595,0002,379,8222,977,919Nov 20, 2012, 04:21 PM
BARRIS PETER J10% OwnerNov 19, 2012 Option Exercise$0.083,3332505,333Nov 20, 2012, 03:51 PM
SANDELL SCOTT D10% OwnerNov 19, 2012 Option Exercise$0.083,3332505,333Nov 20, 2012, 03:50 PM
KRAMLICH C RICHARD10% OwnerNov 19, 2012 Option Exercise$0.083,3332505,333Nov 20, 2012, 03:50 PM
BVF PARTNERS L P/IL10% OwnerNov 16, 2012 Buy$5.1173,500375,4602,646,619Nov 19, 2012, 05:21 PM
BVF PARTNERS L P/IL10% OwnerNov 14, 2012 Buy$4.001,216,7124,866,8482,599,919Nov 19, 2012, 05:21 PM
BVF PARTNERS L P/IL10% OwnerNov 08, 2012 Buy$4.0149,329197,6511,827,856Nov 09, 2012, 04:52 PM
BVF PARTNERS L P/IL10% OwnerNov 07, 2012 Buy$4.0823,10094,2761,795,927Nov 09, 2012, 04:52 PM
BVF PARTNERS L P/IL10% OwnerNov 02, 2012 Buy$4.0557,600233,4821,781,627Nov 02, 2012, 06:35 PM
BVF PARTNERS L P/IL10% OwnerNov 01, 2012 Buy$4.0530,100121,8001,745,527Nov 02, 2012, 06:35 PM
BVF PARTNERS L P/IL10% OwnerOct 31, 2012 Buy$4.0652,000210,8961,738,827Nov 02, 2012, 06:35 PM
BURRILL STEVENDirectorJul 31, 2012 Option Exercise$0.084,3333254,333Aug 01, 2012, 05:22 PM
Richard John PDirectorJun 08, 2012 Buy$4.167,50031,1927,500Jun 11, 2012, 04:54 PM
Bencherif MerouaneSVP, Preclinical ResearchMay 18, 2012 Option Exercise$2.9315,93846,69815,938May 22, 2012, 03:10 PM
deBethizy J DonaldPresident and CEOFeb 14, 2012 Option Exercise$5.107984,070798Feb 16, 2012, 05:54 PM
Richard John PDirectorJul 01, 2011 Option Exercise$9.272,50023,1757,833Jul 06, 2011, 09:20 AM
Richard John PDirectorJul 01, 2011 Sale$21.022,50052,5505,333Jul 06, 2011, 09:20 AM
Musso Alan ASVP, CFO & TreasurerJun 07, 2011 Option Exercise$5.3930,875166,34033,674Jun 08, 2011, 06:31 PM
Musso Alan ASVP, CFO & TreasurerJun 07, 2011 Sale$21.8030,875672,9732,799Jun 08, 2011, 06:31 PM
BROWN JULIA RDirectorMay 13, 2011 Option Exercise$8.709,10079,1709,100May 13, 2011, 07:34 PM
BROWN JULIA RDirectorMay 13, 2011 Sale$23.389,100212,7820May 13, 2011, 07:34 PM
BURRILL STEVENDirectorMay 10, 2011 Option Exercise$9.3716,948158,80316,948May 13, 2011, 07:52 AM
BURRILL STEVENDirectorMay 12, 2011 Option Exercise$7.3233,052241,97233,052May 13, 2011, 07:52 AM
BURRILL STEVENDirectorMay 12, 2011 Sale$23.8833,052789,3450May 13, 2011, 07:52 AM
BURRILL STEVENDirectorMay 10, 2011 Sale$24.132,00048,2530May 13, 2011, 07:52 AM
BURRILL STEVENDirectorMay 10, 2011 Sale$24.0416,948407,4710May 13, 2011, 07:52 AM
BURRILL STEVENDirectorMay 11, 2011 Option Exercise$7.3233,052241,97233,052May 12, 2011, 06:59 PM
BURRILL STEVENDirectorMay 10, 2011 Option Exercise$9.3716,948158,80316,948May 12, 2011, 06:59 PM
BURRILL STEVENDirectorMay 11, 2011 Sale$23.8833,052789,3450May 12, 2011, 06:59 PM
BURRILL STEVENDirectorMay 10, 2011 Sale$24.132,00048,2530May 12, 2011, 06:59 PM
BURRILL STEVENDirectorMay 10, 2011 Sale$24.0416,948407,4710May 12, 2011, 06:59 PM
Richard John PDirectorApr 01, 2011 Option Exercise$9.272,50023,1757,833Apr 04, 2011, 06:41 PM
Richard John PDirectorApr 01, 2011 Sale$26.602,50066,5005,333Apr 04, 2011, 06:41 PM
Caldwell William SSVP - Drug Discovery and Dev.Mar 31, 2011 Option Exercise$2.932,6557,77910,390Apr 04, 2011, 06:34 PM
Caldwell William SSVP - Drug Discovery and Dev.Mar 31, 2011 Sale$26.372,65570,0127,735Apr 04, 2011, 06:34 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 09, 2011 Option Exercise$5.551,5008,3252,659Mar 11, 2011, 04:41 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 09, 2011 Sale$30.001,50045,0001,159Mar 11, 2011, 04:41 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 03, 2011 Option Exercise$5.555,03027,9176,189Mar 09, 2011, 02:53 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 07, 2011 Option Exercise$5.555002,7751,659Mar 09, 2011, 02:53 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 07, 2011 Sale$30.0050015,0011,159Mar 09, 2011, 02:53 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 03, 2011 Sale$30.005,030150,9001,159Mar 09, 2011, 02:53 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 02, 2011 Option Exercise$5.552001,1101,359Mar 03, 2011, 05:10 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 01, 2011 Option Exercise$5.5512,70370,50213,862Mar 03, 2011, 05:10 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 02, 2011 Sale$30.002006,0001,159Mar 03, 2011, 05:10 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerMar 01, 2011 Sale$30.1612,703383,1441,159Mar 03, 2011, 05:10 PM
Brennan Jeffrey PSVP - Bus. & Commercial Dev.Mar 01, 2011 Option Exercise$2.931,2643,7041,264Mar 03, 2011, 05:04 PM
Brennan Jeffrey PSVP - Bus. & Commercial Dev.Mar 01, 2011 Sale$30.001,26437,9200Mar 03, 2011, 05:04 PM
Hicks Karen AVP Human ResourcesMar 01, 2011 Option Exercise$8.441,24310,4891,243Mar 03, 2011, 05:03 PM
Hicks Karen AVP Human ResourcesMar 01, 2011 Sale$30.001,24337,2900Mar 03, 2011, 05:03 PM
Caldwell William SSVP - Drug Discovery and Dev.Mar 01, 2011 Option Exercise$8.5111,36096,67419,095Mar 02, 2011, 06:05 PM
Caldwell William SSVP - Drug Discovery and Dev.Feb 28, 2011 Option Exercise$5.5515,48185,92023,216Mar 02, 2011, 06:05 PM
Caldwell William SSVP - Drug Discovery and Dev.Mar 01, 2011 Sale$30.0011,360340,8007,735Mar 02, 2011, 06:05 PM
Caldwell William SSVP - Drug Discovery and Dev.Feb 28, 2011 Sale$28.0015,481433,4687,735Mar 02, 2011, 06:05 PM
Caldwell William SSVP - Drug Discovery and Dev.Feb 16, 2011 Option Exercise$1.7516,65529,14624,390Feb 18, 2011, 04:42 PM
Caldwell William SSVP - Drug Discovery and Dev.Feb 16, 2011 Sale$26.5216,655441,6567,735Feb 18, 2011, 04:42 PM
Richard John PDirectorJan 19, 2011 Option Exercise$2.715,00013,55010,333Jan 20, 2011, 05:45 PM
Richard John PDirectorJan 18, 2011 Option Exercise$2.712,5006,7757,833Jan 20, 2011, 05:45 PM
Richard John PDirectorJan 18, 2011 Sale$27.382,50068,4405,333Jan 20, 2011, 05:45 PM
Richard John PDirectorJan 19, 2011 Sale$27.115,000135,5425,333Jan 20, 2011, 05:45 PM
Bencherif MerouaneSVP, Preclinical ResearchJan 19, 2011 Option Exercise$2.7530,20383,06930,203Jan 20, 2011, 05:40 PM
Bencherif MerouaneSVP, Preclinical ResearchJan 18, 2011 Option Exercise$5.5522,800126,54022,800Jan 20, 2011, 05:40 PM
Bencherif MerouaneSVP, Preclinical ResearchJan 19, 2011 Sale$27.0930,203818,2570Jan 20, 2011, 05:40 PM
Bencherif MerouaneSVP, Preclinical ResearchJan 18, 2011 Sale$27.1722,800619,4760Jan 20, 2011, 05:40 PM
Hicks Karen AVP Human ResourcesJan 13, 2011 Option Exercise$2.933,3699,8713,369Jan 18, 2011, 06:34 AM
Hicks Karen AVP Human ResourcesJan 14, 2011 Option Exercise$2.931,7195,0371,719Jan 18, 2011, 06:34 AM
Hicks Karen AVP Human ResourcesJan 14, 2011 Sale$27.501,71947,2730Jan 18, 2011, 06:34 AM
Hicks Karen AVP Human ResourcesJan 13, 2011 Sale$27.243,36991,7600Jan 18, 2011, 06:34 AM
Hicks Karen AVP Human ResourcesJan 12, 2011 Option Exercise$5.9111,23166,42011,231Jan 13, 2011, 06:55 PM
Hicks Karen AVP Human ResourcesJan 11, 2011 Option Exercise$6.2613,82586,47913,825Jan 13, 2011, 06:55 PM
Hicks Karen AVP Human ResourcesJan 12, 2011 Sale$27.1811,231305,2980Jan 13, 2011, 06:55 PM
Hicks Karen AVP Human ResourcesJan 11, 2011 Sale$27.0213,825373,5710Jan 13, 2011, 06:55 PM
Musso Alan ASVP, CFO & TreasurerDec 21, 2010 Option Exercise$5.1015,53579,22818,334Dec 23, 2010, 10:11 AM
Musso Alan ASVP, CFO & TreasurerDec 22, 2010 Option Exercise$5.104,88124,8937,680Dec 23, 2010, 10:11 AM
Musso Alan ASVP, CFO & TreasurerDec 21, 2010 Sale$26.6115,535413,3862,799Dec 23, 2010, 10:11 AM
Musso Alan ASVP, CFO & TreasurerDec 22, 2010 Sale$26.474,881129,2002,799Dec 23, 2010, 10:11 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 20, 2010 Option Exercise$1.758,88215,54410,035Dec 21, 2010, 01:46 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 17, 2010 Option Exercise$1.752,1003,6753,253Dec 21, 2010, 01:46 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 20, 2010 Sale$26.028,882231,1201,153Dec 21, 2010, 01:46 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 17, 2010 Sale$26.082,10054,7651,153Dec 21, 2010, 01:46 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerDec 16, 2010 Option Exercise$8.512,70022,9773,859Dec 20, 2010, 11:48 AM
Hodges Mauri KVP Fin + Corp Sys & ControllerDec 16, 2010 Sale$25.242,70068,1421,159Dec 20, 2010, 11:48 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 16, 2010 Option Exercise$1.752003501,353Dec 20, 2010, 11:47 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 16, 2010 Sale$25.152005,0301,153Dec 20, 2010, 11:47 AM
Caldwell William SSVP - Drug Discovery and Dev.Dec 13, 2010 Option Exercise$1.7512,00021,00019,735Dec 14, 2010, 05:24 PM
Caldwell William SSVP - Drug Discovery and Dev.Dec 13, 2010 Sale$23.9512,000287,3777,735Dec 14, 2010, 05:24 PM
Brennan Jeffrey PSVP - Bus. & Commercial Dev.Dec 13, 2010 Option Exercise$2.9310,00029,30010,000Dec 14, 2010, 05:23 PM
Brennan Jeffrey PSVP - Bus. & Commercial Dev.Dec 13, 2010 Sale$23.8610,000238,5530Dec 14, 2010, 05:23 PM
Bencherif MerouaneSVP, Preclinical ResearchDec 10, 2010 Option Exercise$6.0032,093192,53532,093Dec 14, 2010, 05:22 PM
Bencherif MerouaneSVP, Preclinical ResearchDec 10, 2010 Sale$24.0532,093771,9550Dec 14, 2010, 05:22 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 08, 2010 Option Exercise$5.1011,25057,37512,403Dec 10, 2010, 05:43 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsDec 08, 2010 Sale$22.6811,250255,1501,153Dec 10, 2010, 05:43 PM
SKALETSKY MARK BDirectorNov 17, 2010 Option Exercise$7.2329,500213,14540,832Nov 18, 2010, 05:23 PM
SKALETSKY MARK BDirectorNov 16, 2010 Option Exercise$2.713,0008,13014,332Nov 18, 2010, 05:23 PM
SKALETSKY MARK BDirectorNov 17, 2010 Sale$22.0029,500649,00011,332Nov 18, 2010, 05:23 PM
SKALETSKY MARK BDirectorNov 16, 2010 Sale$21.763,00065,29511,332Nov 18, 2010, 05:23 PM
BLIXT CHARLES ADirectorNov 17, 2010 Option Exercise$9.275,50050,9855,500Nov 18, 2010, 05:14 PM
BLIXT CHARLES ADirectorNov 16, 2010 Option Exercise$7.569,50071,7909,500Nov 18, 2010, 05:14 PM
BLIXT CHARLES ADirectorNov 16, 2010 Sale$21.809,500207,0670Nov 18, 2010, 05:14 PM
BLIXT CHARLES ADirectorNov 17, 2010 Sale$21.765,500119,6660Nov 18, 2010, 05:14 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 05, 2010 Option Exercise$1.757001,2251,853Nov 09, 2010, 06:43 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 05, 2010 Sale$25.0270017,5121,153Nov 09, 2010, 06:43 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 05, 2010 Option Exercise$8.511,40011,9142,559Nov 09, 2010, 06:39 PM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 05, 2010 Sale$25.011,40035,0141,159Nov 09, 2010, 06:39 PM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 04, 2010 Option Exercise$1.757,78413,6228,937Nov 05, 2010, 11:27 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 03, 2010 Option Exercise$1.759861,7262,139Nov 05, 2010, 11:27 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 04, 2010 Sale$25.077,784195,1391,153Nov 05, 2010, 11:27 AM
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. AffairsNov 03, 2010 Sale$25.0598624,6991,153Nov 05, 2010, 11:27 AM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 03, 2010 Option Exercise$8.511,0008,5102,159Nov 05, 2010, 11:25 AM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 04, 2010 Option Exercise$8.517,80066,3788,959Nov 05, 2010, 11:25 AM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 03, 2010 Sale$25.061,00025,0551,159Nov 05, 2010, 11:25 AM
Hodges Mauri KVP Fin + Corp Sys & ControllerNov 04, 2010 Sale$25.087,800195,6051,159Nov 05, 2010, 11:25 AM
Musso Alan ASVP, CFO & TreasurerOct 28, 2010 Option Exercise$2.931,5004,3954,299Oct 28, 2010, 05:32 PM
Musso Alan ASVP, CFO & TreasurerOct 26, 2010 Option Exercise$2.932,0005,8604,799Oct 28, 2010, 05:32 PM
Musso Alan ASVP, CFO & TreasurerOct 28, 2010 Sale$24.601,50036,9002,799Oct 28, 2010, 05:32 PM
Musso Alan ASVP, CFO & TreasurerOct 26, 2010 Sale$24.652,00049,2952,799Oct 28, 2010, 05:32 PM
Musso Alan ASVP, CFO & TreasurerOct 25, 2010 Option Exercise$2.938,50024,90511,299Oct 26, 2010, 04:44 PM
Musso Alan ASVP, CFO & TreasurerOct 22, 2010 Option Exercise$2.936001,7583,399Oct 26, 2010, 04:44 PM
Musso Alan ASVP, CFO & TreasurerOct 25, 2010 Sale$24.698,500209,8922,799Oct 26, 2010, 04:44 PM
Musso Alan ASVP, CFO & TreasurerOct 22, 2010 Sale$24.6060014,7602,799Oct 26, 2010, 04:44 PM
DUNTON ALAN WDirectorAug 02, 2010 Option Exercise$5.696,00034,1406,000Aug 03, 2010, 08:07 PM
DUNTON ALAN WDirectorAug 02, 2010 Sale$22.306,000133,7910Aug 03, 2010, 08:07 PM
DUNTON ALAN WDirectorJul 26, 2010 Option Exercise$5.692,86416,2962,864Jul 27, 2010, 07:01 PM
DUNTON ALAN WDirectorJul 23, 2010 Option Exercise$5.692,33613,2922,336Jul 27, 2010, 07:01 PM
DUNTON ALAN WDirectorJul 26, 2010 Sale$21.122,86460,4760Jul 27, 2010, 07:01 PM
DUNTON ALAN WDirectorJul 23, 2010 Sale$21.002,33649,0630Jul 27, 2010, 07:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
USMAN NASSIMDirector04/01/2024138,600
USMAN NASSIMDirector04/01/2024323,000
USMAN NASSIMDirector03/15/2024138,600
USMAN NASSIMDirector03/15/2024345,200
USMAN NASSIMPresident & CEO08/09/20221,527
Miller Seline E.SVP Finance; Interim CFO & PAO08/09/20221,527
Blouse Grant E.Chief Scientific Officer08/09/20221,527
USMAN NASSIMPresident & CEO02/09/20221,495
Miller Seline E.SVP Finance; Interim CFO & PAO02/09/20221,495
Blouse Grant E.Chief Scientific Officer02/09/20221,495
USMAN NASSIMPresident & CEO08/09/20213,139
Levy HowardChief Medical Officer08/09/20212,313
Blouse Grant E.Chief Scientific Officer08/09/20214,210
USMAN NASSIMPresident & CEO04/05/202123,150
USMAN NASSIMPresident & CEO02/09/20212,799
Levy HowardChief Medical Officer02/09/20218,033
USMAN NASSIMPresident & CEO08/10/20202,799
Levy HowardChief Medical Officer08/10/20208,504
Levy HowardChief Medical Officer03/16/202010,131
USMAN NASSIMPresident & CEO03/13/202015,647
Richard John PDirector03/13/20209,950
Cai VeronicaController03/13/20208,220
Williams EddieDirector03/04/202011,560
Ling Geoffrey M.D.Director02/25/202018,692
LAWLOR AUGUSTINEDirector02/25/2020423,506
USMAN NASSIMPresident & CEO02/10/20202,679
Levy HowardChief Medical Officer02/10/20208,460
Cai VeronicaController02/10/202010,454
Payne FletcherChief Financial Officer08/12/20197,682
USMAN NASSIMPresident & CEO08/12/20192,689
Richard John PDirector05/24/20198,030
USMAN NASSIMPresident & CEO05/21/201920,372
Levy HowardChief Medical Officer05/21/201920,372
Payne FletcherChief Financial Officer02/11/20197,054
USMAN NASSIMPresident & CEO02/11/20192,464
Levy HowardChief Medical Officer02/11/201917,494
Levy HowardChief Medical Officer01/31/20196,945
Payne FletcherChief Financial Officer02/04/20196,959
USMAN NASSIMPresident & CEO01/31/201926,525
Levy HowardChief Medical Officer11/26/2018690
Levy HowardChief Medical Officer11/16/2018801
Levy HowardChief Medical Officer11/16/20181,903
HILL STEPHEN ADirector09/06/20181,913
Levy HowardChief Medical Officer05/03/201835,003
USMAN NASSIMPresident & CEO04/04/2018407
Payne FletcherChief Financial Officer03/26/2018273
Flynn James E10% Owner03/08/201874,664
Flynn James E10% Owner03/08/2018196,967
Flynn James E10% Owner03/07/201882,440
Flynn James E10% Owner03/07/2018217,560
Flynn James E10% Owner03/06/2018445,099
Flynn James E10% Owner03/06/20181,174,315
Flynn James E10% Owner03/08/2018271,631
Flynn James E10% Owner03/07/2018300,000
Flynn James E10% Owner03/06/20181,619,414
USMAN NASSIMPresident & CEO12/17/20158,000
Payne FletcherChief Financial Officer12/17/201520,000
HILL STEPHEN ADirector12/17/201510,150
HILL STEPHEN ADirector08/28/201581,621
BARRIS PETER J10% Owner12/05/20135,131
SANDELL SCOTT D10% Owner12/05/20135,131
BARRETT M JAMES10% Owner12/03/201351,525
BARRETT M JAMES10% Owner12/05/20135,131
BARRETT M JAMES10% Owner12/03/201380,754
BARRIS PETER J10% Owner11/21/201327,533
BARRETT M JAMES10% Owner11/21/201327,533
SANDELL SCOTT D10% Owner11/21/201327,533
BARRIS PETER J10% Owner06/03/201375
SANDELL SCOTT D10% Owner06/03/201375
BARRETT M JAMES10% Owner06/03/201375
BROWN JULIA RDirector05/10/201330,534
HILL STEPHEN APresident and CEO03/11/201343,781
HILL STEPHEN APresident and CEO03/08/201344,796
HILL STEPHEN APresident and CEO03/11/201343,781
HILL STEPHEN APresident and CEO03/08/201344,796
BVF PARTNERS L P/IL10% Owner11/16/20122,379,822
BARRIS PETER J10% Owner11/19/2012250
SANDELL SCOTT D10% Owner11/19/2012250
KRAMLICH C RICHARD10% Owner11/19/2012250
BVF PARTNERS L P/IL10% Owner11/16/2012375,460
BVF PARTNERS L P/IL10% Owner11/14/20124,866,848
BVF PARTNERS L P/IL10% Owner11/08/2012197,651
BVF PARTNERS L P/IL10% Owner11/07/201294,276
BVF PARTNERS L P/IL10% Owner11/02/2012233,482
BVF PARTNERS L P/IL10% Owner11/01/2012121,800
BVF PARTNERS L P/IL10% Owner10/31/2012210,896
BURRILL STEVENDirector07/31/2012325
Richard John PDirector06/08/201231,192
Bencherif MerouaneSVP, Preclinical Research05/18/201246,698
deBethizy J DonaldPresident and CEO02/14/20124,070
Richard John PDirector07/01/201123,175
Richard John PDirector07/01/201152,550
Musso Alan ASVP, CFO & Treasurer06/07/2011166,340
Musso Alan ASVP, CFO & Treasurer06/07/2011672,973
BROWN JULIA RDirector05/13/201179,170
BROWN JULIA RDirector05/13/2011212,782
BURRILL STEVENDirector05/10/2011158,803
BURRILL STEVENDirector05/12/2011241,972
BURRILL STEVENDirector05/12/2011789,345
BURRILL STEVENDirector05/10/201148,253
BURRILL STEVENDirector05/10/2011407,471
BURRILL STEVENDirector05/11/2011241,972
BURRILL STEVENDirector05/10/2011158,803
BURRILL STEVENDirector05/11/2011789,345
BURRILL STEVENDirector05/10/201148,253
BURRILL STEVENDirector05/10/2011407,471
Richard John PDirector04/01/201123,175
Richard John PDirector04/01/201166,500
Caldwell William SSVP - Drug Discovery and Dev.03/31/20117,779
Caldwell William SSVP - Drug Discovery and Dev.03/31/201170,012
Hodges Mauri KVP Fin + Corp Sys & Controller03/09/20118,325
Hodges Mauri KVP Fin + Corp Sys & Controller03/09/201145,000
Hodges Mauri KVP Fin + Corp Sys & Controller03/03/201127,917
Hodges Mauri KVP Fin + Corp Sys & Controller03/07/20112,775
Hodges Mauri KVP Fin + Corp Sys & Controller03/07/201115,001
Hodges Mauri KVP Fin + Corp Sys & Controller03/03/2011150,900
Hodges Mauri KVP Fin + Corp Sys & Controller03/02/20111,110
Hodges Mauri KVP Fin + Corp Sys & Controller03/01/201170,502
Hodges Mauri KVP Fin + Corp Sys & Controller03/02/20116,000
Hodges Mauri KVP Fin + Corp Sys & Controller03/01/2011383,144
Brennan Jeffrey PSVP - Bus. & Commercial Dev.03/01/20113,704
Brennan Jeffrey PSVP - Bus. & Commercial Dev.03/01/201137,920
Hicks Karen AVP Human Resources03/01/201110,489
Hicks Karen AVP Human Resources03/01/201137,290
Caldwell William SSVP - Drug Discovery and Dev.03/01/201196,674
Caldwell William SSVP - Drug Discovery and Dev.02/28/201185,920
Caldwell William SSVP - Drug Discovery and Dev.03/01/2011340,800
Caldwell William SSVP - Drug Discovery and Dev.02/28/2011433,468
Caldwell William SSVP - Drug Discovery and Dev.02/16/201129,146
Caldwell William SSVP - Drug Discovery and Dev.02/16/2011441,656
Richard John PDirector01/19/201113,550
Richard John PDirector01/18/20116,775
Richard John PDirector01/18/201168,440
Richard John PDirector01/19/2011135,542
Bencherif MerouaneSVP, Preclinical Research01/19/201183,069
Bencherif MerouaneSVP, Preclinical Research01/18/2011126,540
Bencherif MerouaneSVP, Preclinical Research01/19/2011818,257
Bencherif MerouaneSVP, Preclinical Research01/18/2011619,476
Hicks Karen AVP Human Resources01/13/20119,871
Hicks Karen AVP Human Resources01/14/20115,037
Hicks Karen AVP Human Resources01/14/201147,273
Hicks Karen AVP Human Resources01/13/201191,760
Hicks Karen AVP Human Resources01/12/201166,420
Hicks Karen AVP Human Resources01/11/201186,479
Hicks Karen AVP Human Resources01/12/2011305,298
Hicks Karen AVP Human Resources01/11/2011373,571
Musso Alan ASVP, CFO & Treasurer12/21/201079,228
Musso Alan ASVP, CFO & Treasurer12/22/201024,893
Musso Alan ASVP, CFO & Treasurer12/21/2010413,386
Musso Alan ASVP, CFO & Treasurer12/22/2010129,200
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/20/201015,544
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/17/20103,675
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/20/2010231,120
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/17/201054,765
Hodges Mauri KVP Fin + Corp Sys & Controller12/16/201022,977
Hodges Mauri KVP Fin + Corp Sys & Controller12/16/201068,142
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/16/2010350
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/16/20105,030
Caldwell William SSVP - Drug Discovery and Dev.12/13/201021,000
Caldwell William SSVP - Drug Discovery and Dev.12/13/2010287,377
Brennan Jeffrey PSVP - Bus. & Commercial Dev.12/13/201029,300
Brennan Jeffrey PSVP - Bus. & Commercial Dev.12/13/2010238,553
Bencherif MerouaneSVP, Preclinical Research12/10/2010192,535
Bencherif MerouaneSVP, Preclinical Research12/10/2010771,955
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/08/201057,375
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs12/08/2010255,150
SKALETSKY MARK BDirector11/17/2010213,145
SKALETSKY MARK BDirector11/16/20108,130
SKALETSKY MARK BDirector11/17/2010649,000
SKALETSKY MARK BDirector11/16/201065,295
BLIXT CHARLES ADirector11/17/201050,985
BLIXT CHARLES ADirector11/16/201071,790
BLIXT CHARLES ADirector11/16/2010207,067
BLIXT CHARLES ADirector11/17/2010119,666
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/05/20101,225
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/05/201017,512
Hodges Mauri KVP Fin + Corp Sys & Controller11/05/201011,914
Hodges Mauri KVP Fin + Corp Sys & Controller11/05/201035,014
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/04/201013,622
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/03/20101,726
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/04/2010195,139
Dunbar Geoffrey CSVP, Clin. Dev. & Reg. Affairs11/03/201024,699
Hodges Mauri KVP Fin + Corp Sys & Controller11/03/20108,510
Hodges Mauri KVP Fin + Corp Sys & Controller11/04/201066,378
Hodges Mauri KVP Fin + Corp Sys & Controller11/03/201025,055
Hodges Mauri KVP Fin + Corp Sys & Controller11/04/2010195,605
Musso Alan ASVP, CFO & Treasurer10/28/20104,395
Musso Alan ASVP, CFO & Treasurer10/26/20105,860
Musso Alan ASVP, CFO & Treasurer10/28/201036,900
Musso Alan ASVP, CFO & Treasurer10/26/201049,295
Musso Alan ASVP, CFO & Treasurer10/25/201024,905
Musso Alan ASVP, CFO & Treasurer10/22/20101,758
Musso Alan ASVP, CFO & Treasurer10/25/2010209,892
Musso Alan ASVP, CFO & Treasurer10/22/201014,760
DUNTON ALAN WDirector08/02/201034,140
DUNTON ALAN WDirector08/02/2010133,791
DUNTON ALAN WDirector07/26/201016,296
DUNTON ALAN WDirector07/23/201013,292
DUNTON ALAN WDirector07/26/201060,476
DUNTON ALAN WDirector07/23/201049,063
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.47%
1Q
09/30/2023
03/31/2023
-0.02%
2Q
09/30/2023
12/31/2022
21.08%
3Q
09/30/2023
09/30/2022
20.62%
4Q
09/30/2023
06/30/2022
20.63%
5Q
09/30/2023
03/31/2022
20.73%
6Q
09/30/2023
12/31/2021
20.88%
7Q
09/30/2023
09/30/2021
21.02%
8Q
09/30/2023
06/30/2021
21.14%
9Q
09/30/2023
03/31/2021
33.79%
10Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.47%
1Q
03/31/2023
-0.02%
2Q
12/31/2022
21.08%
3Q
09/30/2022
20.62%
4Q
06/30/2022
20.63%
5Q
03/31/2022
20.73%
6Q
12/31/2021
20.88%
7Q
09/30/2021
21.02%
8Q
06/30/2021
21.14%
9Q
03/31/2021
33.79%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...